Evidence map›Paper›PMID 27022745›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2016

Interaction between STAT3 gene polymorphisms and smoking on Crohn's disease susceptibility: a case-control study in a Chinese Han population.

Jun-Hong Li, Ning Wu, Hong-Mei Yang, Hong-Bing Tang, Dong-Ping Bao, Jun-Min Ji

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jun-Hong LiInspection Center, Changzhou Center for Disease Control and Prevention, No. 203, Taishan Road, The New North District, Changzhou, 213022, Jiangsu, People's Republic of China.
Ning WuDepartment of Clinical Laboratory, The First Hospital of Hengyang, Hengyang, 421001, Hunan, People's Republic of China.
Hong-Mei YangDepartment of Blood Quality Management, Changzhou Blood Center, Changzhou, 213004, Jiangsu, People's Republic of China.
Hong-Bing TangInspection Center, Changzhou Center for Disease Control and Prevention, No. 203, Taishan Road, The New North District, Changzhou, 213022, Jiangsu, People's Republic of China.
Dong-Ping BaoInspection Center, Changzhou Center for Disease Control and Prevention, No. 203, Taishan Road, The New North District, Changzhou, 213022, Jiangsu, People's Republic of China.
Jun-Min JiInspection Center, Changzhou Center for Disease Control and Prevention, No. 203, Taishan Road, The New North District, Changzhou, 213022, Jiangsu, People's Republic of China. jijunmin3313@163.com.
Hengyang Academy of Agricultural Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe aim of this study was to investigate the impact of the signal transducer and activator of transcription 3 (STAT3) gene and additional STAT3 gene-smoking interaction on Crohn's disease (CD) risk based on a Chinese population.

methodsA total of 1012 participants (491 men, 521 women), were selected, including 502 CD patients and 510 normal controls. The mean age of all participants was 42.3 ± 11.2 years. Logistic regression model was used to examine the association between single nucleotide polymorphism (SNP) of STAT3 and CD risk; the odds ratio (OR) and 95 % confident interval (95 % CI) were calculated. Generalized multifactor dimensionality reduction was employed to analyze the interaction among several SNPs.

resultsLogistic analysis showed the significant association between genotypes of variants in two SNP and decreased CD risk, after covariates adjustment. The carriers of homozygous mutant of two SNP polymorphism revealed decreased CD risk than those with wild-type homozygotes; OR (95 % CI) was 0.75 (0.59-0.93) and 0.68 (0.57-0.91), respectively. There was a significant two-locus model (p = 0.0107) involving rs744166 and smoking, indicating a potential gene-environment interaction between rs744166 and smoking. Overall, the cross-validation consistency was 10/10, and the testing accuracy was 62.17 %, and never smokers with TC or CC genotype have the lowest CD risk, compared to smokers with TT genotype; OR (95 % CI) was 0.52 (0.31-0.82), after covariate adjustment.

conclusionsOur results support an important association of rs744166 and rs4796793 with decreased CD risk, and additional interaction between rs744166 and smoking.

Indexed as

AdultAsian PeopleCase-Control StudiesChinaCrohn DiseaseFemaleGenotypeHumansMaleMiddle AgedOdds RatioPolymorphism, Single NucleotideSmokingSTAT3 Transcription FactorSTAT3 protein, humanSTAT3 Transcription FactorCrohn’s diseaseInteractionSmokingSNPSTAT3

Identifiers

PMID27022745
OpenAlexW2324734229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.